Clough Capital Partners LP increased Orbotech Ltd (ORBK) stake by 89.42% reported in 2017Q4 SEC filing. Clough Capital Partners LP acquired 48,339 shares as Orbotech Ltd (ORBK)’s stock rose 23.02%. The Clough Capital Partners LP holds 102,400 shares with $5.15 million value, up from 54,061 last quarter. Orbotech Ltd now has $2.83 billion valuation. The stock decreased 0.19% or $0.11 during the last trading session, reaching $58.33. About 82,134 shares traded. Orbotech Ltd. (NASDAQ:ORBK) has risen 91.25% since April 20, 2017 and is uptrending. It has outperformed by 79.70% the S&P500.
Analysts expect Omnicell, Inc. (NASDAQ:OMCL) to report $-0.04 EPS on May, 3.They anticipate $0.25 EPS change or 86.21% from last quarter’s $-0.29 EPS. After having $0.28 EPS previously, Omnicell, Inc.’s analysts see -114.29% EPS growth. The stock decreased 1.82% or $0.8 during the last trading session, reaching $43.1. About 51,788 shares traded. Omnicell, Inc. (NASDAQ:OMCL) has risen 5.20% since April 20, 2017 and is uptrending. It has underperformed by 6.35% the S&P500.
Since December 15, 2017, it had 0 buys, and 4 selling transactions for $520,345 activity. PETERSMEYER GARY S had sold 575 shares worth $25,544 on Thursday, March 15. 1,926 shares valued at $99,559 were sold by Kuipers Peter J. on Friday, December 15. LIPPS RANDALL A sold $361,938 worth of stock or 8,186 shares.
Omnicell, Inc. provides automation and business analytics software solutions for medication and supply management in healthcare worldwide. The company has market cap of $1.68 billion. The firm operates through two divisions, Automation and Analytics, and Medication Adherence. It has a 81.32 P/E ratio. It offers Omnicell Automated Dispensing Cabinets, a dispensing system, which automates the management and dispensing of medications; SinglePointe, a software product that controls medications; AnywhereRN, which remotely queue medications from automated dispensing cabinets; Omnicell Analytics and Pandora Analytics reporting and data analytics tools; and Savvy Mobile Medication Workstation, which provides a platform for hospital information systems.
Among 10 analysts covering Omnicell (NASDAQ:OMCL), 7 have Buy rating, 0 Sell and 3 Hold. Therefore 70% are positive. Omnicell had 27 analyst reports since July 31, 2015 according to SRatingsIntel. Benchmark initiated it with “Buy” rating and $33.0 target in Thursday, January 7 report. On Thursday, October 26 the stock rating was maintained by Cantor Fitzgerald with “Buy”. The stock of Omnicell, Inc. (NASDAQ:OMCL) earned “Outperform” rating by FBR Capital on Friday, October 30. The firm has “Buy” rating by Craig Hallum given on Monday, October 30. Oppenheimer maintained it with “Buy” rating and $55.0 target in Monday, January 29 report. As per Thursday, September 3, the company rating was maintained by FBR Capital. The stock of Omnicell, Inc. (NASDAQ:OMCL) earned “Outperform” rating by Oppenheimer on Friday, July 31. The rating was maintained by Oppenheimer with “Buy” on Friday, October 27. Dougherty & Company initiated it with “Buy” rating and $44 target in Thursday, January 19 report. The firm earned “Buy” rating on Tuesday, December 5 by Cantor Fitzgerald.
Investors sentiment increased to 1.12 in Q4 2017. Its up 0.10, from 1.02 in 2017Q3. It is positive, as 14 investors sold Omnicell, Inc. shares while 72 reduced holdings. 27 funds opened positions while 69 raised stakes. 37.38 million shares or 0.77% more from 37.10 million shares in 2017Q3 were reported. Tiaa Cref Mngmt Ltd Llc holds 138,245 shares. Westwood Group accumulated 528,618 shares or 0.19% of the stock. Tower Capital Ltd Liability Corporation (Trc) invested 0.01% of its portfolio in Omnicell, Inc. (NASDAQ:OMCL). Parkside Fincl Bank And Tru holds 21 shares or 0% of its portfolio. Usa Fincl Portformulas owns 0.09% invested in Omnicell, Inc. (NASDAQ:OMCL) for 7,502 shares. National Bank & Trust Of Montreal Can owns 1,702 shares for 0% of their portfolio. 87,628 are held by California Pub Employees Retirement System. Millennium Mgmt Ltd Co stated it has 0% of its portfolio in Omnicell, Inc. (NASDAQ:OMCL). Braun Stacey Associate holds 0.63% in Omnicell, Inc. (NASDAQ:OMCL) or 193,615 shares. Texas Yale Corp invested in 0.08% or 18,350 shares. State Street Corporation reported 1.11 million shares stake. Rockefeller Svcs has 469,672 shares for 0.36% of their portfolio. Moreover, Cubist Systematic Strategies Llc has 0.01% invested in Omnicell, Inc. (NASDAQ:OMCL) for 4,370 shares. Impact Advsr Lc has invested 0.57% in Omnicell, Inc. (NASDAQ:OMCL). Stephens Inv Mngmt Gru Limited Liability invested in 0.47% or 421,205 shares.
Clough Capital Partners LP decreased Citigroup Inc (NYSE:C) stake by 173,800 shares to 692,743 valued at $51.55M in 2017Q4. It also reduced Starwood Ppty Tr Inc (NYSE:STWD) stake by 217,100 shares and now owns 2.31M shares. D R Horton Inc (NYSE:DHI) was reduced too.